Terms: = Uterine cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
45 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. [Treatment and prognosis analysis of 488 patients with FIGO 2018 stage Ⅲc squamous cervical cancer].
Feng T; Shou HF; Yuan SH; Tang HR; Lyu XJ; Yin ZM; Lou HM; Ni J
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):359-367. PubMed ID: 37217343
[No Abstract] [Full Text] [Related]
3. The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
Cho WK; Kim HS; Park W; Kim YS; Kang J; Kim YB; Kim YS; Kim YJ; Kim KR; Kim JH; Kwon SY; Choi JH; Yoon M; Kim NI
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):154-163. PubMed ID: 36935025
[TBL] [Abstract] [Full Text] [Related]
4. PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
Xue Y; Dong Y; Lou Y; Lv Q; Shan W; Wang C; Chen X
J Gynecol Oncol; 2023 Jul; 34(4):e53. PubMed ID: 36929579
[TBL] [Abstract] [Full Text] [Related]
5. Endometrial cancer of the very elderly: Management and survival in the Francogyn population.
Martin FA; Dion L; Nyangoh Timoh K; Dupré PF; Azaïs H; Bendifallah S; Touboul C; Dabi Y; Graesslin O; Raimond E; Costaz H; Kerbage Y; Huchon C; Mimoun C; Koskas M; Akladios C; Lecointre L; Canlorbe G; Chauvet P; Ouldamer L; Levêque J; Lavoué V
Eur J Surg Oncol; 2023 May; 49(5):1023-1030. PubMed ID: 36707344
[TBL] [Abstract] [Full Text] [Related]
6. Construction of circRNA-associated ceRNA network reveals the regulation of fibroblast proliferation in cervical cancer.
Sun W; Hang D; Han S; Fu S; Ma H; Dong X; Xu Y; Li N; Hu Z
Gene; 2022 Nov; 844():146824. PubMed ID: 35995117
[TBL] [Abstract] [Full Text] [Related]
7. prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical cancer.
Lang X; Huang C; Cui H
J Immunol Res; 2022; 2022():4954457. PubMed ID: 35942212
[TBL] [Abstract] [Full Text] [Related]
8. Spirulina phycocyanin extract and its active components suppress epithelial-mesenchymal transition process in endometrial cancer via targeting TGF-beta1/SMAD4 signaling pathway.
Chen HY; Chiang YF; Huang CY; Shieh TM; Kao C; Chang FK; Huang TC; Ali M; Chang HY; Hong YH; Hsia SM
Biomed Pharmacother; 2022 Aug; 152():113219. PubMed ID: 35691155
[TBL] [Abstract] [Full Text] [Related]
9. Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?
Shiri Aghbash P; Shirvaliloo M; Khalo Abass Kasho A; Alinezhad F; Nauwynck H; Bannazadeh Baghi H
Int Immunopharmacol; 2022 Jul; 108():108896. PubMed ID: 35640377
[TBL] [Abstract] [Full Text] [Related]
10. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Kashofer K; Regauer S; Reich O; Petru E; Winter E
Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
[TBL] [Abstract] [Full Text] [Related]
11. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract] [Full Text] [Related]
12. Trends in hysterectomy-corrected uterine cancer mortality rates during 2002 to 2015: mortality of nonendometrioid cancer on the rise?
Gustafson LW; Booth BB; Kahlert J; Ørtoft G; Mejlgaard E; Clarke MA; Wentzensen N; Rositch AF; Hammer A
Int J Cancer; 2021 Feb; 148(3):584-592. PubMed ID: 32683690
[TBL] [Abstract] [Full Text] [Related]
13. PreImplantation Factor immunohistochemical expression correlates with prostate cancer aggressiveness.
Raspollini MR; Montagnani I; Cirri P; Baroni G; Cimadamore A; Scarpelli M; Cheng L; Lopez-Beltran A; Montironi R; Barnea ER
Int J Biol Markers; 2020 Jun; 35(2):82-90. PubMed ID: 32389051
[TBL] [Abstract] [Full Text] [Related]
14. Risk of Gynecologic cancer as Second versus First Primary cancer in Japan.
Ogawa C; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Masuyama H
Acta Med Okayama; 2020 Apr; 74(2):109-114. PubMed ID: 32341584
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of apc.
Yang C; Ota-Kurogi N; Ikeda K; Okumura T; Horie-Inoue K; Takeda S; Inoue S
J Biochem; 2020 Jul; 168(1):7-14. PubMed ID: 32003827
[TBL] [Abstract] [Full Text] [Related]
16. [Lymph node management in endometrial cancer].
Owen C; Bendifallah S; Jayot A; Ilenko A; Arfi A; Boudy AS; Richard S; Varinot J; Thomassin-Naggara I; Bazot M; Daraï É
Bull Cancer; 2020 Jun; 107(6):686-695. PubMed ID: 31648773
[TBL] [Abstract] [Full Text] [Related]
17. Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma.
Ino Y; Akimoto T; Takasawa A; Takasawa K; Aoyama T; Ueda A; Ota M; Magara K; Tagami Y; Murata M; Hasegawa T; Saito T; Sawada N; Osanai M
Histol Histopathol; 2020 Apr; 35(4):351-359. PubMed ID: 31483053
[TBL] [Abstract] [Full Text] [Related]
18. High expression of glutamate-ammonia ligase is associated with unfavorable prognosis in patients with ovarian cancer.
Fan S; Wang Y; Zhang Z; Lu J; Wu Z; Shan Q; Sun C; Wu D; Li M; Sheng N; Xie Y; Zheng Y
J Cell Biochem; 2018 Jul; 119(7):6008-6015. PubMed ID: 29575012
[TBL] [Abstract] [Full Text] [Related]
19. HPV infection and p16
Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
[TBL] [Abstract] [Full Text] [Related]
20. Incidence Patterns and Survival of Gynecological Sarcoma in Germany: Analysis of Population-Based cancer Registry Data on 1066 Women.
Pietzner K; Buttmann-Schweiger N; Sehouli J; Kraywinkel K
Int J Gynecol Cancer; 2018 Jan; 28(1):134-138. PubMed ID: 29040191
[TBL] [Abstract] [Full Text] [Related]
[Next]
